ClinicalTrials.gg
Enrolling by invitationNCT07943858Updated Nov 17, 2026

Can Spending Time in Nature Help Mothers With Depression After Childbirth? A 6-Week Forest Therapy Study

An interventional study of Forest Therapy Group and Standard Care (in control arm) in Postpartum Depression, Postpartum Depression (PPD) and Postnatal Depression, sponsored by Hong Kong Baptist University. Enrolling by invitation at 1 site in China. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Hong Kong Baptist University · Not applicable, Interventional, and Treatment

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 21 studies in Depression, Postpartum with a site in China — 10 open to participants now, 11 under way, 1 of them phase 3. Depression, Postpartum · China.

Planned enrollment
18th of 18
40 · median 237
Started
2026
with 5 others
No phase
10 of 21
6 open now
Primary completion
2027-05
later than 6 of 10 live
Registered
21st of 21
by date
Lead sponsor
1 of 21
Hong Kong Baptist University

Among the 21 studies in Depression, Postpartum with a site in China, this one is the 18th largest by planned enrollment of the 18 interventional ones that give a count, is one of 6 that started in 2026, is one of 10 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 21st registered.

Depression, Postpartum

569 studies on the registry are indexed under Depression, Postpartum; 134 are open to participants now.

Browse Depression, Postpartum studies →

Open to participants now

10 of the 21 studies in Depression, Postpartum with a site in China are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 87 Depression, Postpartum studies recruiting now, 54 (62%) set no upper age limit and 30 (34%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Depression, Postpartum with a site in China, or all of them as a file.
02

Study summary

This study aims to test a 6-week nature-based program called "Forest for Mothers" to help women with mild-to-moderate postpartum depression (PPD). PPD is common, but current treatments can be hard to access or may not be safe for breastfeeding mothers. We are testing whether spending time in nature in a group setting can improve mood and well-being.

We will recruit 40 mothers who gave birth within the last 3 years and have mild-to-moderate depressive symptoms. Participants will be randomly assigned to either a forest therapy group or a standard care group. The forest therapy group will attend weekly 2-hour guided sessions in an urban forest park for 6 weeks. These sessions include gentle walking, sensory exercises, meditation, group sharing, and nature-based creative activities. The standard care group will receive an information booklet on postpartum depression management.

All participants will complete questionnaires about their mood, stress, sleep, and quality of life at the start of the study, after 6 weeks, and at 3- and 6-month follow-ups. We hope to find that this nature-based program is an effective, accessible, and safe non-drug option to help mothers feel better.

Read the detailed description

This study aims to develop and test a nature-based intervention (Forest for Mothers, FfM) for postpartum depression (PPD). PPD affects 15-20% of mothers globally, but current treatments face limitations in accessibility, cost, and medication safety during lactation.

The study consists a definitive, assessor-blinded, randomized controlled trial (RCT) to test the efficacy of a standardized 6-week forest therapy intervention.

Participants (N=40) will be recruited from community health centers and maternity hospitals in Shanghai, China. Eligible participants are women within 36 months postpartum, aged 18 or above, with an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 10, indicating mild-to-moderate depression. Exclusion criteria include severe mental illness or active suicidal ideation.

The intervention group will receive the 6-week forest therapy program plus standard care, while the control group will receive standard care alone (including an information booklet). The program consists of weekly 120-minute sessions in urban forest parks, facilitated by a trained social worker/psychologist and an assistant. Sessions include sensory exercises, mindful walking, guided meditation, group sharing, and nature-based creative activities. Childcare support will be provided on-site.

Outcome assessments will be conducted at baseline, post-intervention (week 6), 3-month, and 6-month follow-ups. The primary outcome is the change in depressive symptoms measured by the EPDS. Secondary outcomes include anxiety (GAD-7), perceived stress (PSS), quality of life (WHOQOL-BREF), sleep quality (PSQI), and heart rate variability (HRV). A subset of participants will be invited to an audio-recorded semi-structured interview to explore their experiences, perceived benefits, and challenges.

Safety protocols include on-site first aid kits, facilitators trained in basic first aid, a licensed mental health professional on the research team, emergency contingency plans, and a referral pathway for community mental health services. Participants may pause or stop participation at any time.

03

Conditions studied

  • Postpartum Depression
  • Postpartum Depression (PPD)
  • Postnatal Depression

Keywords

  • Forest Therapy, Nature-based Intervention, Postpartum Depression, Postnatal depression, Randomized Controlled Trial
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18 years or older.
  • Postpartum within 36 months after childbirth.
  • Score of 10 or higher on the Edinburgh Postnatal Depression Scale (EPDS),
  • Willing to provide and comply with study procedures.
  • Medical clearance for light outdoor physical activity.

Exclusion criteria

Exclusion Criteria:

  • Current severe mental illness (e.g., schizophrenia, bipolar disorder).
  • Active suicidal ideation or self-harm risk (confirmed via clinical interview).
  • Currently pregnant. (If a participant becomes pregnant during the study, they must notify the researchers immediately, and participation will be paused or terminated based on safety assessment).
  • Physical conditions that prevent safe participation in light outdoor activities.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Forest Therapy Group

    Participants receive standard care plus a 6-week forest therapy program (one 120-minute session per week in an urban forest park). Sessions include sensory exercises, mindful walking, guided meditation, group sharing, and nature-based creative activities.

    Behavioral: Forest Therapy Group

  • Active comparator
    Control Group

    Participants receive information on postpartum depression management.

    Behavioral: Standard Care (in control arm)

Interventions

  • BehavioralForest Therapy Group

    A standardized 6-week forest therapy program called "Forest for Mothers" (FfM). Participants attend one 120-minute session per week in an urban forest park, guided by a trained facilitator (social worker or psychologist) and an assistant. Sessions include sensory exercises, mindful walking, guided meditation, group sharing, and nature-based creative activities. The program also includes weekly "nature homework" (e.g., a one-minute nature pause). Childcare support is provided on-site during sessions.

  • BehavioralStandard Care (in control arm)

    Offering participants information about postpartum depression management.

06

What researchers measure

Primary outcomes

  1. Change in Depressive Symptoms (EPDS Score)

    The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire used to assess depressive symptoms. Scores range from 0 to 30, with higher scores indicating more severe depressive symptoms. The primary outcome is the change in EPDS score from baseline to post-intervention (Week 6).

    Time frame: Baseline, Week 6, 3-month, and 6-month follow-ups

Secondary outcomes

  1. Change in Anxiety Symptoms (GAD-7 Score)

    The Generalized Anxiety Disorder 7-item (GAD-7) scale. Scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.

    Time frame: Baseline, Week 3-month, and 6-month follow-ups

  2. Change in Perceived Stress (PSS Score)

    The 10-item Perceived Stress Scale (PSS). Scores range from 0 to 40, with higher scores indicating higher levels of perceived stress.

    Time frame: Baseline, Week 6

  3. Change in Quality of Life (WHOQOL-BREF Score)

    The World Health Organization Quality of Life-Brief Version (WHOQOL-BREF). This 26-item questionnaire assesses physical health, psychological health, social relationships, and environment. Higher scores indicate better quality of life.

    Time frame: Baseline, Week 6

  4. Change in Sleep Quality (PSQI Score)

    The Pittsburgh Sleep Quality Index (PSQI). Scores range from 0 to 21, with higher scores indicating worse sleep quality.

    Time frame: Baseline, Week 6

  5. Change in Heart Rate Variability (HRV)

    Heart rate variability will be measured using a small, non-invasive wearable monitor (similar to a smartwatch) worn by participants to assess physiological stress response.

    Time frame: Baseline, Week 6

Other outcomes

  1. Participants' Experiences and Perceived Benefits

    Semi-structured audio-recorded interviews will be conducted with a subset of participants (approximately 10-15 from the intervention group) to explore their experiences, perceived benefits, challenges, and suggestions for the "Forest for Mothers" program.

    Time frame: Post-intervention (Week 6)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared. This is a small-scale doctoral study (N=40) involving sensitive mental health data (including postpartum depression questionnaires and audio-recorded interviews). Sharing raw IPD would pose risks to participant privacy and confidentiality. Additionally, the study team does not have the resources or institutional infrastructure to establish a formal data-sharing repository.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for May 2027, 7 months after the start.

Of 257 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 7 months is below that.

Counting every sponsor, half of 263 studies reached it within 23 months; a quarter within 11 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartActual
Sep 30, 2026
Primary completionEst.
May 20, 2027
CompletionEst.
May 20, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943858
Lead sponsor
Hong Kong Baptist University
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Sep 30, 2026
Primary completion
May 20, 2027 (estimated)
Completion
May 20, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Yingqi Guo, PhD
study director · Hong Kong Baptist University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion